Volume : 13, Issue : 01, January – 2026
Title:
COMPUTATIONAL ANALYSIS OF PIPER LONGUM BIOACTIVE COMPOUNDS TARGETING COVID 19 VIRUS M PRO
Authors :
Prabha.B, Shamlin E. Ashwini, Jeyasheely.J.
Abstract :
Background: The COVID-19 pandemic, caused by SARS-CoV-2, has posed a significant global health threat. Despite advances in medicine, effective treatments remain limited. The COVID-19 main protease (Mpro) is a crucial enzyme for viral replication, making it an attractive target for drug development. Piper longum, a traditional medicinal plant, has shown antiviral and therapeutic properties, making it a potential candidate for COVID-19 treatment. This study explores the potential of piper longum bioactive compounds as COVID-19 Mpro inihibitors through molecular docking.
Material and Methods: Ten phytochemical constituents of Piper longum were selected and docked against COVID-19 Mpro (PDB ID: 6LU7) using molecular docking tools. The protein structure was obtained from the Protein Data Bank, and ligand structures were retrieved from PubChem.
Results: All selected ligands showed good binding energy towards COVID-19 Mpro, ranging from -5.59 kcal/mol to -9.56 kcal/mol. Piperundecalidine exhibited the highest binding affinity (-9.56 kcal/mol), indicating its potential as a COVID-19 Mpro inhibitor. The study highlights the potential of Piper longum bioactive compounds as COVID-19 Mpro inhibitors, with Piperundecalidine showing promising results. The findings suggest that Piper longum, a traditionally used medicinal plant, could be a potential herbal remedy against COVID-19.
Conclusion:The study identifies Piper longum bioactive compounds, particularly Piperundecalidine, as potential COVID-19 Mpro inhibitors, warranting further in vitro and in vivo evaluations to repurpose the fruit of Piper longum against COVID-19.
KEYWORDS: COVID-19, Piper longum, Protein, Ligand, Molecular docking
Cite This Article:
Please cite this article in press Shamlin E. Ashwini et al., Computational analysis of piper longum Bioactive compounds targeting covid 19 virus M pro, Indo Am. J. P. Sci, 2026; 13(01).
REFERENCES:
1. Muhammad Adnan Shereen, Suliman Khan, Abeer Kazmi, Nadia Bashir, Rabeea Siddique. COVID-19 infection: Origin, transmission, and characteristics of human Coronaviruses. Journal of Advanced Research, 2020; 24: 91–98.
2. RCSB PDB, Biological Macromolecular Structures Enabling Breakthroughs in Research and Education, http://www.rcsb.org/news.
3. Kanchan Anand, Gottfried Palm J, Jeroen Mesters R, Stuart Siddell G, John Ziebuhr,Rolf Hilgenfeld. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain. The EMBO Journal, 2002; 21: 3213- 3224.
4. Yang H, Yang M, Ding Y, Liu Y, Lou Z, Zhou Z, Sun L, Mo L, Ye S, Pang H, Gao GF, Anand K, Bartlam M, Hilgenfeld R, Rao Z. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 2003; 100: 13190- 13195.
5. Suresh Kumar, Jitpal Kamboj, Suman, Sunil Sharma. Overview for Various Aspects of the Health Benefits of Piper Longum Linn. Fruit. J Acupunct Meridian Stud, 2011; 4(2): 134−140.
6. Vivek Srivastava, Satya Prakash Gupta, Mohd. Imran Siddiqi, BhartenduNath Mishra. Molecular docking studies on quinazoline antifolate derivatives as human thymidylate synthase inhibitors. Bioinformation, 2010; 4(8): 357-365.
7. Liu X, Zhang B, Jin Z, Yang H, Rao Z. Structure of Mpro from COVID-19 virus and discovery of its Inhibitors. Nature, https://doi.org/10.1038/s41586-020-2223-y 2019.
8. Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, Hutchison GR. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminform, 2012; 4:17.
9. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. Autodock4 and Auto Dock Tools 4: automated docking with selective receptor flexiblity.J.ComputationalChemistry,2009;30(16):2785–2791
10. Shityakov S, Förster C. In silico predictive model to deter-mine vector-mediated transport properties for the blood–brainbarrier choline transporter.AdvApplBioinform Chem, 2014; 7:23.
11. Washington Overview of Rational Drug Design by M. Rami Reddy and Abby L. Parrill ACS: DC 1999.